EXMT (EXMT) Stock Price & Analysis
EXMT (EXMT) rose 0.00% to USD 0 as of July 25, 2026 at 06:46 UTC, according to Nexqual real-time market data.
EXMT last closed at USD 0; the session ranged USD 0–0 on volume of 1 shares. Market capitalization is $1.44M, with a 52-week range of USD 0–0 (OID). Source: Nexqual, July 25, 2026 at 06:46 UTC.
Key Statistics (as of July 25, 2026 at 06:46 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 1 shares |
| Market Cap | $1.44M |
| Exchange | OID |
Technical Analysis (EXMT)
Nexqual's technical model rates EXMT "NEUTRAL" based on 3 bullish and 2 bearish signals across 124 daily candles, as of July 25, 2026 at 06:46 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 40.99 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (EXMT)
Wall Street analysts rate EXMT "None", per Nexqual as of July 25, 2026 at 06:46 UTC.
| Consensus Rating | None |
|---|
Earnings (EXMT)
Source: Nexqual, July 25, 2026 at 06:46 UTC.
Financials & Fundamentals (EXMT)
| Total Revenue | $257,696 |
|---|---|
| Revenue Growth (YoY) | +178.50% |
| Gross Margin | +43.87% |
| Operating Margin | -936.58% |
| Profit Margin | +0.00% |
| Debt / Equity | 0.98 |
| Current Ratio | 0.02 |
| Total Cash | $342 |
| Total Debt | $122,000 |
Source: Nexqual, July 25, 2026 at 06:46 UTC.
Financial Health Score (EXMT)
Nexqual rates EXMT's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 06:46 UTC.
| Growth | Strong — Revenue +179% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Solid — $342 cash, no debt |
| Cash Flow | Weak — Operating cash flow -$3M |
| Efficiency | Mixed — No data |
Ownership (EXMT)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 4.80B |
Source: Nexqual, July 25, 2026 at 06:46 UTC.
Leadership (EXMT)
EXMT is led by Lee Katterman, Chief Executive Officer, per Nexqual as of July 25, 2026 at 06:46 UTC.
| Chief Executive Officer | Lee Katterman |
|---|---|
| President & Director | Richard Wilson |
| Chief Financial Officer | Martin Zezula |
| Vice President of Administration | Faisel Naim (age 50) |
| Vice President of Marketing | Amy Wang |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ICBU | IMD Companies, Inc. | USD 0 | ▲ 0% |
| SKTO | SK3 GROUP INC | USD 0 | ▲ 0% |
| NTRR | Neutra Corp. | USD 0 | ▲ 0% |
| PLPL | Plandai Biotechnology, Inc. | USD 0 | ▲ 0% |
| REFG | Medical Cannabis Payment Soluti | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:46 UTC. This page is informational and not investment advice.